The Clinical and Scientific team at NeoImmuneTech oversees the design, execution, and management of clinical trials for the company's lead drug candidate, NT-I7. This includes collaborating with industry leaders, ensuring compliance with regulatory standards, and managing day-to-day clinical operations to advance the drug through various trial phases. The team coordinates efforts to enhance immuno-oncology and infectious disease treatments by supporting robust scientific research and driving clinical development.
View all